News
BNGO
1.110
+1.83%
0.020
Weekly Report: what happened at BNGO last week (0318-0322)?
Weekly Report · 4d ago
Bionano Announces Publication Of A Breast Cancer Study Showing That The Number Of SVs Detected With OGM May Be Related To Prognosis, Tumor Progression And Chemotherapy Resistance
Study of optical genome mapping (OGM) in hereditary breast and ovarian cancer (HBOC) syndrome. Researchers found tumors with higher numbers of structural variations (SVs) tended to have more mutated genes and altered signaling pathways. OGM was able to detect novel gene fusions in cancer with high accuracy.
Benzinga · 03/19 12:15
Weekly Report: what happened at BNGO last week (0311-0315)?
Weekly Report · 03/18 10:48
Weekly Report: what happened at BNGO last week (0304-0308)?
Weekly Report · 03/11 10:46
BioNano Genomics (BNGO) Gets a Hold from Maxim Group
TipRanks · 03/09 16:15
Bionano Genomics Is Maintained at Sector Outperform by Scotiabank
Dow Jones · 03/07 13:53
Bionano Genomics Price Target Cut to $6.00/Share From $7.00 by Scotiabank
Dow Jones · 03/07 13:53
Scotiabank Maintains Sector Outperform on Bionano Genomics, Lowers Price Target to $6
Benzinga · 03/07 13:43
A New Cause for Concern: Bionano Genomics Adds a New Share Price & Shareholder Rights Risk
TipRanks · 03/07 06:01
Bionano Genomics Inc: Annual report
Press release · 03/06 04:08
Bionano Genomics Q4 Sales $10.721M Beat $10.585M Estimate
Benzinga · 03/05 21:18
*Bionano Genomics Expects to Continue Exploring Strategic Opportunities >BNGO
Dow Jones · 03/05 21:07
*Bionano Genomics Sees Reducing Annual Operating Expense by Another Estimated $35 M to $40.0 M >BNGO
Dow Jones · 03/05 21:06
*Bionano Genomics Sees Potential Reduction in Headcount by Additional 110 to 125 Employees >BNGO
Dow Jones · 03/05 21:06
*Bionano Genomics Anticipates Installation of 80 to 100 New OGM Systems in 2024 >BNGO
Dow Jones · 03/05 21:05
*Bionano Genomics Sees FY Rev $37M-$41M >BNGO
Dow Jones · 03/05 21:05
*Bionano Genomics Sees 1Q Rev $8.25M-$8.75M >BNGO
Dow Jones · 03/05 21:05
Bionano Genomics reports Q4 results
Seeking Alpha · 03/05 21:03
*Bionano Genomics 4Q Rev $10.7M >BNGO
Dow Jones · 03/05 21:01
Options Volatility and Implied Earnings Moves Today, March 05, 2024
TipRanks · 03/05 12:05
More
Webull provides a variety of real-time BNGO stock news. You can receive the latest news about Bionano Genomics Inc through multiple platforms. This information may help you make smarter investment decisions.
About BNGO
Bionano Genomics, Inc. is a genomics company, which provides optical genome mapping (OGM) for genome analysis. The Company offers diagnostic services to physicians specializing in medical management for individuals with genetic conditions, such as pediatric neurodevelopmental disorders, including autism spectrum disorders. It markets and sells the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation. Its Lineagen business provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. Through its BioDiscovery business, it offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants and absence of heterozygosity across the genome in one consolidated view.